Which Compliance Trends Are Impacting Medical Device Purchasing?

Medical device purchasing has become increasingly connected to regulatory compliance, quality management, cybersecurity, traceability, and supplier oversight. Hospitals, clinics, healthcare systems, and other organizations can no longer evaluate medical devices solely according to price, availability, specifications, or brand reputation. Procurement teams must also consider whether products and suppliers can support applicable regulatory, quality, documentation, and patient-safety requirements.

These expectations are becoming particularly important as regulatory frameworks evolve. In the United States, the FDA’s Quality Management System Regulation (QMSR) became effective on February 2, 2026, incorporating ISO 13485:2016 into the FDA’s medical device quality framework. At the same time, cybersecurity expectations for connected devices are becoming more prominent, while unique device identification and supply-chain traceability continue to influence how healthcare organizations manage devices throughout their lifecycle.

Key Takeaways

• The FDA’s Quality Management System Regulation (QMSR) is changing the compliance environment for medical device manufacturers and influencing how healthcare organizations evaluate suppliers.
• Quality management and supplier oversight are becoming more important components of medical device procurement.
• Medical device cybersecurity is increasingly relevant when purchasing connected, network-enabled, or software-dependent devices.
• Unique Device Identification (UDI) supports better device identification, inventory management, traceability, and postmarket surveillance.
• Procurement teams should place greater emphasis on documentation, traceability, and product verification before accepting medical devices.
• Risk-based purchasing can help healthcare organizations apply greater scrutiny to devices and suppliers associated with higher patient, operational, or regulatory risks.
• Compliance should be treated as an ongoing procurement responsibility, rather than a one-time check performed before a purchase.

QMSR Is Changing The Medical Device Compliance Environment

One of the most significant recent developments affecting medical device compliance is the FDA’s implementation of the Quality Management System Regulation.

The QMSR became effective on February 2, 2026, amending the device current good manufacturing practice requirements in 21 CFR Part 820. The regulation incorporates by reference ISO 13485:2016, the international standard addressing quality management systems for medical devices. The FDA also replaced its previous Quality System Inspection Technique with an updated inspection process aligned with the QMSR.

Although the QMSR primarily establishes requirements for manufacturers, its impact can extend into healthcare procurement. Hospitals and healthcare organizations rely on manufacturers, distributors, and suppliers to provide products that meet applicable quality and regulatory expectations.

What QMSR Means For Purchasing Teams

Procurement professionals may increasingly need to ask questions such as:

• Does the manufacturer maintain an appropriate quality management system?
• Is the device manufactured under processes designed to support consistent quality?
• Can the supplier provide appropriate regulatory and product documentation?
• Are quality records and certifications current?
• Does the supplier have processes for handling complaints, corrective actions, recalls, and other quality issues?
• Can the supplier provide reliable information about the products being purchased?

The FDA notes that QMSR inspections can include examination of quality-related records, including supplier audits, internal audits, and management review reports.

For healthcare organizations, this reinforces the importance of treating supplier qualification as part of an overall quality strategy.

Supplier Qualification And Quality Oversight Are Becoming More Important

A medical device procurement decision is also a supplier decision. Even when a device appears to meet clinical and technical requirements, problems with documentation, sourcing, storage, distribution, or quality management can create downstream risks.

As compliance expectations become more sophisticated, organizations may place greater emphasis on supplier qualification before purchase.

What Should Healthcare Organizations Evaluate?

A supplier evaluation process may include:

This approach can help procurement teams move beyond simply asking whether a supplier can provide a product.

Instead, the question becomes whether the supplier can consistently provide the right product, with the right documentation, through a reliable and compliant supply chain.

Why Supplier Documentation Matters

Documentation can become particularly important when a healthcare organization needs to demonstrate how a product was selected, verified, received, stored, or distributed.

A strong procurement process should make it easier to answer questions such as:

• What device was purchased?
• Who supplied it?
• Which manufacturer produced it?
• What model or catalog number was involved?
• What lot or serial number was received?
• Was the product within its expiration date?
• What regulatory information supported the purchase?
• Can the product be traced if a recall occurs?

Building these questions into purchasing procedures can strengthen both operational control and compliance readiness.

Cybersecurity Is Becoming A Procurement Consideration

Medical device cybersecurity is another important trend affecting purchasing decisions.

Many modern medical devices rely on software, networks, wireless communications, cloud platforms, electronic health records, or other digital technologies. As a result, cybersecurity can become relevant not only to information technology departments but also to procurement teams.

In February 2026, the FDA issued updated final guidance addressing cybersecurity considerations in medical device quality management systems and premarket submissions. The guidance provides recommendations concerning device design, labeling, and documentation for devices with cybersecurity risks.

Connected Devices Require Additional Questions

When evaluating connected medical devices, healthcare organizations may need to consider:

• How does the device connect to the organization’s network?
• What type of patient or operational information does it process?
• Does the device require software updates?
• How are cybersecurity vulnerabilities communicated?
• What security controls are available?
• How long will security support be provided?
• What happens if the manufacturer identifies a vulnerability?
• Does the device integrate with existing hospital systems?
• What access controls are available?

These questions can help procurement teams identify risks before a device becomes part of the healthcare organization’s technology environment.

Procurement And IT Should Work Together

For connected medical devices, procurement decisions should not be made in isolation.

Clinical, purchasing, information technology, cybersecurity, biomedical engineering, compliance, and other relevant teams may all have an interest in the device. Bringing these stakeholders into the purchasing process can help organizations identify regulatory, clinical, technical, and security considerations before committing to a product.

UDI And Traceability Are Influencing Device Purchasing

The FDA’s Unique Device Identification system is another important compliance consideration.

The UDI system was established to adequately identify medical devices from manufacturing through distribution and patient use. Under the UDI framework, applicable device labels and packages generally include a unique device identifier, while device information is submitted to the Global Unique Device Identification Database (GUDID).

UDI information can include device identifiers as well as production information such as lot or batch numbers, serial numbers, expiration dates, or manufacturing dates, depending on the device.

Why UDI Matters To Procurement

UDI can support several activities that directly or indirectly affect purchasing and inventory management:

• Product identification
• Inventory accuracy
• Receiving processes
• Device tracking
• Recall management
• Product verification
• Supply-chain visibility
• Patient safety
• Postmarket surveillance

The FDA has specifically emphasized the importance of integrating UDI information into electronic systems throughout the healthcare system, including supply chains, electronic health records, and registries.

For procurement teams, this means product identification should not necessarily end when an item is ordered.

Organizations may also need processes for accurately recording device information when products are received and incorporated into inventory.

Improving Traceability

A procurement system that captures appropriate device information can make it easier to determine which products are currently in stock, where they are located, and whether a specific lot or model needs to be removed.

This becomes especially important when a manufacturer issues a recall or safety communication.

Risk-Based Purchasing Is Gaining Importance

Not every medical device presents the same level of risk. A basic supply may require a different evaluation process than a sophisticated device that supports diagnosis, monitoring, treatment, or life-sustaining care.

This is why risk-based purchasing is an increasingly useful compliance concept.

The FDA’s QMSR implementation includes a stronger emphasis on risk-based approaches, and the FDA held a 2026 town hall specifically addressing risk-based inspections under the new framework.

Applying Risk To Procurement

Healthcare organizations can consider factors such as:

• The device’s intended clinical use
• Potential impact on patient safety
• Complexity of the device
• Whether the device is software-enabled
• Whether the device connects to a network
• Consequences of device failure
• Availability of alternative products
• Required maintenance and servicing
• Supplier reliability
• Regulatory status
• Recall history and postmarket information

Higher-risk products may warrant more extensive supplier qualification and documentation.

A Risk-Based Procurement Framework

Organizations could categorize devices according to procurement risk and establish different review requirements for each category.

For example:

Lower-risk products

• Standard product verification
• Basic supplier documentation
• Routine inventory controls

Moderate-risk products

• Additional regulatory documentation
• Supplier quality review
• More detailed receiving procedures
• Periodic supplier evaluation

Higher-risk or connected devices

• Cross-functional clinical and technical review
• Detailed regulatory and quality documentation
• Cybersecurity assessment
• Enhanced supplier qualification
• Stronger traceability and lifecycle management

The specific approach should be appropriate to the organization’s policies, applicable regulations, and the characteristics of the device.

Documentation and Product Verification Are Becoming More Critical

Another major compliance trend is the growing importance of accurate documentation. A healthcare organization may need to demonstrate that a medical device was appropriately evaluated and purchased. That means procurement records should provide more than basic information about price and quantity.

Important Documentation May Include

Depending on the device and purchasing environment, organizations may maintain:

• Product identification information
• Manufacturer information
• Supplier information
• Regulatory documentation
• Product specifications
• Instructions for use
• UDI information
• Lot or serial numbers
• Expiration dates
• Purchase orders
• Receiving records
• Quality documentation
• Recall or safety communications
• Service and maintenance records

Maintaining this information can improve an organization’s ability to investigate problems and respond to recalls or other safety concerns.

Verification Before Receiving

Compliance should also extend to the receiving process.

Receiving personnel can verify whether the delivered product matches the purchase order and approved specifications. Depending on the product, this may involve checking:

1. Manufacturer and product identity
2. Model or catalog number
3. Quantity
4. Packaging condition
5. Lot or serial information
6. Expiration date
7. UDI information where applicable
8. Required documentation
9. Shipping and storage conditions

A discrepancy should be documented and addressed through established procedures rather than allowing questionable products to move directly into clinical inventory.

Lifecycle Compliance Is Replacing One-Time Procurement Checks

Medical device compliance does not necessarily end when a purchase order is approved.

A device can remain in use for months or years, during which time its regulatory status, software, cybersecurity profile, maintenance requirements, or supplier support may change.

This makes lifecycle management an increasingly important part of medical device purchasing.

From Purchasing To Postmarket Management

A strong procurement process can connect purchasing activities with:

• Receiving
• Inventory management
• Installation
• Training
• Maintenance
• Servicing
• Software updates
• Cybersecurity monitoring
• Complaint management
• Recall response
• Replacement planning
• Disposal

This approach recognizes that procurement is only one stage of a device’s lifecycle.

Supplier Performance Should Be Monitored

Healthcare organizations may also benefit from periodically reviewing supplier performance rather than assuming that an initially qualified supplier will remain suitable indefinitely.

Performance indicators could include:

• Delivery reliability
• Product quality
• Documentation accuracy
• Response to complaints
• Recall communication
• Technical support
• Service responsiveness
• Product availability
• Regulatory changes
• Cybersecurity notifications

Regular supplier reviews can help procurement teams identify potential problems before they affect clinical operations.

How Can Healthcare Organizations Adapt To These Compliance Trends?

The regulatory environment surrounding medical devices will continue to evolve. Healthcare organizations can prepare by making compliance a consistent component of procurement rather than treating it as a separate administrative requirement.

A practical approach may include the following steps:

1. Establish Supplier Qualification Procedures

Define the documentation and quality information required before a supplier can provide medical devices.

2. Standardize Product Verification

Create receiving procedures that verify product identity, quantity, condition, expiration information, and applicable identification data.

3. Incorporate Risk Into Purchasing Decisions

Use the potential clinical, operational, cybersecurity, and regulatory risks associated with a device to determine the appropriate level of review.

4. Coordinate Across Departments

Involve procurement, clinical, compliance, IT, cybersecurity, biomedical engineering, and other relevant departments when purchasing higher-risk or connected devices.

5. Maintain Accurate Records

Keep procurement and device records organized so products can be identified and traced when needed.

6. Monitor Regulatory Changes

Compliance requirements can change over time. Procurement teams should stay informed about FDA regulations, guidance, and other requirements relevant to the devices they purchase.

7. Review Suppliers Periodically

Supplier qualification should be an ongoing process that considers performance, quality, documentation, responsiveness, and regulatory developments.

Why Compliance Should Be Part Of Every Medical Device Purchasing Strategy

Compliance-focused purchasing can provide benefits that extend beyond regulatory readiness.

A well-structured procurement process can help healthcare organizations reduce the likelihood of receiving incorrect or improperly documented products, improve inventory visibility, support recall response, and strengthen relationships between purchasing and clinical teams.

It can also help organizations make better purchasing decisions by considering the total lifecycle of a medical device rather than focusing exclusively on its initial purchase price.

As regulatory expectations become more interconnected with quality systems, cybersecurity, traceability, and risk management, healthcare organizations should consider compliance an important component of value.

Conclusion

Compliance trends are changing how healthcare organizations evaluate and purchase medical devices. The FDA’s QMSR, cybersecurity expectations, UDI requirements, risk-based approaches, stronger supplier oversight, and increased emphasis on documentation all point toward a more comprehensive approach to medical device procurement.

For hospitals, clinics, and other healthcare organizations, the goal is not simply to purchase a device that meets an immediate clinical need. Procurement teams should also consider whether the product can be appropriately verified, documented, traced, maintained, and supported throughout its useful life. By incorporating compliance into supplier qualification and purchasing procedures, organizations can build a more reliable procurement process while supporting patient safety and operational continuity.

Merit Pharmaceutical can support healthcare organizations seeking dependable medical device sourcing and procurement solutions. A compliance-conscious approach can help organizations make informed purchasing decisions while keeping quality, documentation, and patient needs at the center of the process.

Frequently Asked Questions

1. What Is The Biggest Compliance Trend Affecting Medical Device Purchasing?

One of the most significant current developments is the FDA’s Quality Management System Regulation (QMSR), which became effective on February 2, 2026. The QMSR incorporates ISO 13485:2016 into the FDA’s medical device quality framework and changes how the FDA approaches quality system inspections.

2. Does QMSR Directly Regulate Hospital Purchasing Departments?

QMSR primarily applies to manufacturers and certain other entities subject to FDA medical device quality requirements. However, its emphasis on quality management and supplier-related controls can influence how healthcare organizations evaluate manufacturers and suppliers.

3. Why Is Cybersecurity Important When Purchasing Medical Devices?

Connected medical devices may interact with networks, software, patient information, and other healthcare systems. Evaluating cybersecurity during procurement can help organizations identify potential security and lifecycle-management concerns before a device is integrated into their environment. The FDA issued updated cybersecurity guidance in February 2026 addressing quality management considerations and premarket submissions.

4. What Is UDI In Medical Device Procurement?

UDI stands for Unique Device Identification. The FDA’s UDI system is designed to provide standardized identification of applicable medical devices from manufacturing through distribution and patient use. UDI information can support inventory management, traceability, recall response, and postmarket surveillance.

5. Should Hospitals Evaluate Medical Device Suppliers Before Purchasing?

Yes. Supplier qualification can help healthcare organizations evaluate product documentation, quality processes, regulatory information, traceability, distribution practices, and postmarket support before purchasing medical devices.

6. How Can Procurement Teams Improve Medical Device Compliance?

Procurement teams can establish supplier qualification procedures, verify products before accepting them, maintain accurate device records, incorporate risk assessments into purchasing decisions, monitor regulatory developments, and periodically evaluate supplier performance.

7. Is Compliance Only Important When Purchasing High-Risk Medical Devices?

Compliance is relevant to all applicable medical device purchases, but the level of review can reasonably vary according to the device’s risk, intended use, complexity, connectivity, and potential impact on patient safety. A risk-based approach can help organizations allocate greater oversight to higher-risk products.

8. Why Is Traceability Important After A Medical Device Is Purchased?

Traceability allows healthcare organizations to identify specific products, lots, models, or serial numbers when investigating quality concerns, responding to recalls, managing inventory, or addressing safety communications. The FDA’s UDI system is intended to improve device identification throughout the healthcare supply chain and lifecycle.

9. What Should Organizations Look For When Evaluating A Medical Device Supplier?

Organizations can consider regulatory and quality documentation, product identification, supplier performance, traceability capabilities, distribution practices, complaint and recall processes, technical support, cybersecurity considerations for connected devices, and the supplier’s ability to provide consistent documentation.

10. How Often Should Medical Device Suppliers Be Reviewed?

The appropriate frequency depends on the organization’s policies, supplier risk, device type, purchasing volume, and applicable requirements. Higher-risk suppliers or products may warrant more frequent or more comprehensive reviews than routine purchases.